|
Stryker Corporation (SYK) DCF Valoración
US | Healthcare | Medical - Devices | NYSE
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Stryker Corporation (SYK) Bundle
¿Busca evaluar el valor intrínseco de Stryker Corporation? Nuestra calculadora SYK DCF integra datos del mundo real con extensas características de personalización, lo que le permite refinar sus pronósticos y mejorar sus opciones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,884.0 | 14,351.0 | 17,108.0 | 18,449.0 | 20,498.0 | 22,269.8 | 24,194.7 | 26,286.1 | 28,558.2 | 31,026.6 |
| Revenue Growth, % | 0 | -3.58 | 19.21 | 7.84 | 11.11 | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 |
| EBITDA | 4,176.0 | 3,755.0 | 4,646.0 | 4,536.0 | 4,934.0 | 5,791.8 | 6,292.4 | 6,836.3 | 7,427.2 | 8,069.2 |
| EBITDA, % | 28.06 | 26.17 | 27.16 | 24.59 | 24.07 | 26.01 | 26.01 | 26.01 | 26.01 | 26.01 |
| Depreciation | 778.0 | 812.0 | 990.0 | 998.0 | 1,028.0 | 1,206.9 | 1,311.2 | 1,424.5 | 1,547.7 | 1,681.4 |
| Depreciation, % | 5.23 | 5.66 | 5.79 | 5.41 | 5.02 | 5.42 | 5.42 | 5.42 | 5.42 | 5.42 |
| EBIT | 3,398.0 | 2,943.0 | 3,656.0 | 3,538.0 | 3,906.0 | 4,584.9 | 4,981.2 | 5,411.8 | 5,879.6 | 6,387.8 |
| EBIT, % | 22.83 | 20.51 | 21.37 | 19.18 | 19.06 | 20.59 | 20.59 | 20.59 | 20.59 | 20.59 |
| Total Cash | 4,425.0 | 3,024.0 | 3,019.0 | 1,928.0 | 3,053.0 | 4,177.5 | 4,538.6 | 4,930.9 | 5,357.1 | 5,820.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2,893.0 | 2,701.0 | 3,022.0 | 3,565.0 | 3,765.0 | 4,169.5 | 4,529.9 | 4,921.5 | 5,346.9 | 5,809.0 |
| Account Receivables, % | 19.44 | 18.82 | 17.66 | 19.32 | 18.37 | 18.72 | 18.72 | 18.72 | 18.72 | 18.72 |
| Inventories | 3,282.0 | 3,494.0 | 3,314.0 | 3,995.0 | 4,843.0 | 4,946.1 | 5,373.6 | 5,838.1 | 6,342.7 | 6,891.0 |
| Inventories, % | 22.05 | 24.35 | 19.37 | 21.65 | 23.63 | 22.21 | 22.21 | 22.21 | 22.21 | 22.21 |
| Accounts Payable | 675.0 | 810.0 | 1,129.0 | 1,413.0 | 1,517.0 | 1,418.1 | 1,540.6 | 1,673.8 | 1,818.5 | 1,975.7 |
| Accounts Payable, % | 4.54 | 5.64 | 6.6 | 7.66 | 7.4 | 6.37 | 6.37 | 6.37 | 6.37 | 6.37 |
| Capital Expenditure | -649.0 | -487.0 | -525.0 | -588.0 | -575.0 | -748.9 | -813.7 | -884.0 | -960.4 | -1,043.4 |
| Capital Expenditure, % | -4.36 | -3.39 | -3.07 | -3.19 | -2.81 | -3.36 | -3.36 | -3.36 | -3.36 | -3.36 |
| Tax Rate, % | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 | 13.83 |
| EBITAT | 2,762.7 | 2,408.3 | 3,196.0 | 3,109.4 | 3,365.8 | 3,893.6 | 4,230.1 | 4,595.8 | 4,993.0 | 5,424.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,608.3 | 2,848.3 | 3,839.0 | 2,579.4 | 2,874.8 | 3,745.0 | 4,062.3 | 4,413.4 | 4,794.9 | 5,209.4 |
| WACC, % | 8.36 | 8.36 | 8.38 | 8.38 | 8.37 | 8.37 | 8.37 | 8.37 | 8.37 | 8.37 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 17,344.9 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 5,418 | |||||||||
| Terminal Value | 124,006 | |||||||||
| Present Terminal Value | 82,969 | |||||||||
| Enterprise Value | 100,314 | |||||||||
| Net Debt | 10,024 | |||||||||
| Equity Value | 90,290 | |||||||||
| Diluted Shares Outstanding, MM | 384 | |||||||||
| Equity Value Per Share | 235.32 |
What You Will Get
- Editable Forecast Inputs: Easily adjust assumptions (growth %, margins, WACC) to generate various scenarios.
- Real-World Data: Stryker Corporation’s (SYK) financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that tailors to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.
Key Features
- Customizable Financial Inputs: Adjust essential factors such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and various outputs in real-time.
- High-Precision Accuracy: Leverages Stryker Corporation’s (SYK) actual financial data for dependable valuation results.
- Simplified Scenario Analysis: Effortlessly evaluate different assumptions and analyze results side-by-side.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Stryker Corporation (SYK) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Stryker Corporation (SYK)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Stryker Corporation (SYK)?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses all in one convenient package.
- Customizable Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Stryker’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Stryker Corporation (SYK).
Who Should Use This Product?
- Healthcare Professionals: Understand the financial metrics that drive companies like Stryker Corporation (SYK).
- Researchers: Utilize advanced models to analyze trends in the medical device industry.
- Investors: Evaluate your investment strategies and assess the valuation of Stryker Corporation (SYK).
- Financial Analysts: Enhance your analysis with a customizable DCF model specifically for Stryker Corporation (SYK).
- Business Students: Explore how major players like Stryker Corporation (SYK) are valued in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Stryker Corporation (SYK) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Stryker Corporation (SYK).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.